Evidence map›Paper›PMID 29955653›Full record

ReviewAlzheimer's & dementia (New York, N. Y.)2018

Measuring cognition and function in the preclinical stage of Alzheimer's disease.

Sandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, Terry E Goldberg, James A Hendrix, Judith Jaeger, David S Knopman, Jessica B Langbaum, Denise C Park, Michael T Ropacki and 9 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Alzheimer's & dementia (New York, N. Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05153941 (DNS Cohort Study Aimed at Understanding the Pathophysiology of AD and AD Related Disorders), which is not on this map. Cited by 78 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05153941 active not recruitingnot on this mapstarted 2022, after this paper: background citation

DNS Cohort Study Aimed at Understanding the Pathophysiology of AD and AD Related Disorders (ADRD)

TypeobservationalSponsorAltoidaRan2022 to 2030Enrolled3,500ConditionsAlzheimer's Disease, Mild Cognitive Impairment
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 2 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Study design and results of the Wave VI Add Health Cognitive Assessment, Physical, and Sensory Function (Add CAPS) protocol.The journals of gerontology. Series B, Psychological sciences and social sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 16 institutions in 4 countries.

Sandra WeintraubCognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Maria C CarrilloAlzheimer's Association, Chicago, IL, USA.
Sarah Tomaszewski FariasUniversity of California Davis, Sacramento, CA, USA.
Terry E GoldbergDivision of Geriatric Psychiatry, New York, NY, USA.
James A HendrixAlzheimer's Association, Chicago, IL, USA.
Judith JaegerCognition Metrics, LLC, Wilmington, DE, USA.
David S KnopmanMayo Clinic College of Medicine, Rochester, MN, USA.
Jessica B LangbaumBanner Alzheimer's Institute, Phoenix, AZ, USA.
Denise C ParkThe University of Texas at Dallas, Dallas, TX, USA.
Michael T RopackiMedAvante, Hamilton, NJ, USA.
Sietske A M SikkesAlzheimer Center, VU University Medical Center, Amsterdam, Netherlands.
Kathleen A Welsh-BohmerDuke University, Durham, NC, USA.
Lisa J BainIndependent Science Writer, Elverson, PA, USA.
Robert BrashearJanssen Research and Development, Titusville, New Jersey, USA.
Kumar BudurAbbVie Inc., North Chicago, Illinois, USA.
Ana GrafNovartis Pharma AG, Basel, Switzerland.
Ferenc MartenyiF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Marta Segardahl StorckLundbeck Pharma, Copenhagen, Denmark.
Christopher RandolphMedAvante-Prophase, Hamilton, NJ, USA.
Alzheimer's Association · USAbbVie (United States) · USAlbert Einstein College of Medicine · USAmerican Geriatrics Society · USAmsterdam UMC Location VUmc · NLBanner Alzheimer’s InstituteDuke University · USJanssen (United States) · USLoyola University Medical Center · USLundbeck (Denmark) · DKMayo Clinic · USNorthwestern University · USNovartis (Switzerland) · CHRoche (Switzerland) · CHThe University of Texas at Dallas · USUniversity of California, Davis · US

Funding

Dallas Lifespan Brain Study-Wave 3: Neurodegeneration & Resilience in CognitionRF1AG006265 · NIA · UNIVERSITY OF TEXAS DALLAS · PI PARK, DENISE CORTIS · 2017 to 2019
$7.1M
NIA NIH HHS RF1 AG006265
6 · The paper itself

Abstract

The Alzheimer's Association's Research Roundtable met in November 2016 to explore how best to measure changes in cognition and function in the preclinical stage of Alzheimer's disease. This review will cover the tools and instruments currently available to identify populations for prevention trials, and measure subtle disease progression in the earliest stages of Alzheimer's disease, and will include discussions of suitable cognitive, behavioral, functional, composite, and biological endpoints for prevention trials. Current prevention trials are reviewed including TOMMOROW, Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Trial, the Alzheimer's Prevention Initiative Generation Study, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer's to compare current approaches and tools that are being developed.

Identifiers

PMID29955653
PMCPMC6021264
OpenAlexW2790394929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.